Grant: Discovery Grants Program - Individual
McGill University
$32,000.00
Protein trafficking during placental development: the role of TMED2
EF 2010-11
Résumé
To discover genes that are required for embryonic development we used a forward genetic screen to identify mouse mutants that were abnormal at E9.5 and dead prior to birth. The 99J line was identified in this recessive N-Ethyl-nitrous-urea (ENU) screen and therefore the gene mutated in this line is required for normal development. 99J homozygous mutant embryos are developmentally delayed as early as E8.5 and die by E12.5. At E9.5 these mutants have a failure of chorioallantoic attachment and labyrinth development. We mapped the 99J mutation to mouse chromosome 5F and identified a single point mutation,point mutation in the first exon of transmembrane emp24 domain trafficking protein 2 (p24beta/Tmed2 herein referred to as Tmed2). This mutation results in a non-synonymous substitution of an alanine to glutamic acid in the signal sequence of TMED2. We have also found that this mutation results in a significant decrease in TMED2 expression in 99J homozygous mutant embryos.
TMED proteins, 10 of which has been identified in vertebrate, form oligomeric complexes which interact with newly synthesized proteins and coat-complex protein (COP) to facilitate quality control and transport between the ER and Golgi. Therefore, dysfunctions in these processes are most likely responsible for abnormal placental development in the 99J mutant line. My hypothesis is that Tmed2 is required for normal movement of specific proteins from the ER to the Golgi during placental development. The goal of my proposal is to determine how mutation in Tmed2 and abnormal ER and Golgi protein movement contribute to the failure of placental development in the 99J ENU line.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
341510-2008
Name nom
JeromeMajewska, Loydie
Department département
Pediatrics
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5003
Research subject group en
Genetics
Research subject group fr
Génétique
Research subject en
Developmental genetics
Research subject fr
Génétique du développement
Partie
3
Nb partie
5
Application title
Protein trafficking during placental development: the role of TMED2
Keyword
NSERC
Application summary
To discover genes that are required for embryonic development we used a forward genetic screen to identify mouse mutants that were abnormal at E9.5 and dead prior to birth. The 99J line was identified in this recessive N-Ethyl-nitrous-urea (ENU) screen and therefore the gene mutated in this line is required for normal development. 99J homozygous mutant embryos are developmentally delayed as early as E8.5 and die by E12.5. At E9.5 these mutants have a failure of chorioallantoic attachment and labyrinth development. We mapped the 99J mutation to mouse chromosome 5F and identified a single point mutation,point mutation in the first exon of transmembrane emp24 domain trafficking protein 2 (p24beta/Tmed2 herein referred to as Tmed2). This mutation results in a non-synonymous substitution of an alanine to glutamic acid in the signal sequence of TMED2. We have also found that this mutation results in a significant decrease in TMED2 expression in 99J homozygous mutant embryos.
TMED proteins, 10 of which has been identified in vertebrate, form oligomeric complexes which interact with newly synthesized proteins and coat-complex protein (COP) to facilitate quality control and transport between the ER and Golgi. Therefore, dysfunctions in these processes are most likely responsible for abnormal placental development in the 99J mutant line. My hypothesis is that Tmed2 is required for normal movement of specific proteins from the ER to the Golgi during placental development. The goal of my proposal is to determine how mutation in Tmed2 and abnormal ER and Golgi protein movement contribute to the failure of placental development in the 99J ENU line.